Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06762548 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 23, 2025 (before its estimated September 11, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Nov 21, 2025 to Sep 11, 2026
    • Start date: Jan 24, 2025 to Oct 10, 2025
    • Study completion date: Dec 19, 2025 to Nov 6, 2026
    v3
  2. Primary endpoint revised
    • Secondary endpoints expanded, about 11 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Clinical Study of DA-007 As a Treatment for Chemotherapy Induced Alopecia
Trial Details
NCT Number NCT06762548
Lead Sponsor Applied Biology, Inc.
Collaborators: Daniel Alain, Inc., Follea International Limited
Conditions
(from sponsor)		 Chemotherapy Induced Alopecia, Chemotherapy Side Effects
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov